Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Significance of Claudin Expression in Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2022 | 36232536 | PubTator, text mining | PubMed |
| Upregulation of claudin‑4 by Chinese traditional medicine Shenfu attenuates lung tissue damage by acute lung injury aggravated by acute gastrointestinal injury. | Pharm Biol | 2022 | 36226770 | PubTator, text mining | PubMed |
| Epigenome-Wide Study Identifies Epigenetic Outliers in Normal Mucosa of Patients with Colorectal Cancer. | Cancer Prev Res (Phila) | 2022 | 36219239 | PubTator, text mining | PubMed |
| Infant nutrition affects the microbiota-gut-brain axis: Comparison of human milk vs. infant formula feeding in the piglet model. | Front Nutr | 2022 | 36211510 | PubTator, text mining | PubMed |
| Bacteroides fragilis ameliorates Cronobacter malonaticus lipopolysaccharide-induced pathological injury through modulation of the intestinal microbiota. | Front Immunol | 2022 | 36211338 | PubTator, text mining | PubMed |
| The role of TRPV4 channels in cutaneous epithelia. | Curr Top Membr | 2022 | 36210147 | PubTator, text mining | PubMed |
| Expression of vimentin alters cell mechanics, cell-cell adhesion, and gene expression profiles suggesting the induction of a hybrid EMT in human mammary epithelial cells. | Front Cell Dev Biol | 2022 | 36200046 | PubTator, text mining | PubMed |
| lncRNA PVT1: a novel oncogene in multiple cancers. | Cell Mol Biol Lett | 2022 | 36195846 | PubTator, text mining | PubMed |
| Crypt-Villus Scaffold Architecture for Bioengineering Functional Human Intestinal Epithelium. | ACS Biomater Sci Eng | 2022 | 36191009 | PubTator, text mining | PubMed |
| D-tagatose protects against oleic acid-induced acute respiratory distress syndrome in rats by activating PTEN/PI3K/AKT pathway. | Front Immunol | 2022 | 36189316 | PubTator, text mining | PubMed |
| Expression profiling of mRNA and functional network analyses of genes regulated by human papilloma virus E6 and E7 proteins in HaCaT cells. | Front Microbiol | 2022 | 36188003 | PubTator, text mining | PubMed |
| Identification of Diagnostic Exosomal LncRNA-miRNA-mRNA Biomarkers in Colorectal Cancer Based on the ceRNA Network. | Pathol Oncol Res | 2022 | 36185995 | PubTator, text mining | PubMed |
| The urothelium: a multi-faceted barrier against a harsh environment. | Mucosal Immunol | 2022 | 36180582 | PubTator, text mining | PubMed |
| Sarcomatoid Carcinoma of the Ascending Colon: A Case Report and Literature Review. | Am J Case Rep | 2022 | 36176184 | PubTator, text mining | PubMed |
| Transcriptomic analysis shows that surgical treatment is likely to influence the endometrial receptivity of patients with stage III/IV endometriosis. | Front Endocrinol (Lausanne) | 2022 | 36171908 | PubTator, text mining | PubMed |
| Occludin and claudin-1 are potential prognostic biomarkers in patients with oral squamous cell carcinomas: An observational study. | Oral Surg Oral Med Oral Pathol Oral Radiol | 2022 | 36167722 | PubTator, text mining | PubMed |
| Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe. | World J Gastroenterol | 2022 | 36159004 | PubTator, text mining | PubMed |
| Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy. | World J Gastroenterol | 2022 | 36158273 | PubTator, text mining | PubMed |
| NF-κB: A novel therapeutic pathway for gastroesophageal reflux disease? | World J Clin Cases | 2022 | 36157831 | PubTator, text mining | PubMed |
| Molecular Crosstalk between the Immunological Mechanism of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Oral Cancer. | Vaccines (Basel) | 2022 | 36146567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=39